Neoadjuvant chemotherapy against newly diagnosed CNS germ-cell tumors: A case report

Mehrnosh Aeinfar, Mehrdad Payandeh, Mohammad Samadian, Nasrin Amiryfard, Mohammaderfan Zare, Mohammadebrahim Soltany, Masoud Sadeghi, Edris Sadeghi


Intracranial germ cell tumors (GCTs) are rare brain tumors that typically arise in the pineal or suprasellar regions. A young man (22 years old) was presented with complaint of one year of headache, and recently vomiting, and in exam papilledema, lethargy, somnolence, diabetes insipidus. A Phase II trial with carboplatin based regimen was conducted in this newly diagnosed patient histologically and was confirmed radiologically evaluable CNS germinomas before they received radiotherapy. This patient was presented with a localized hypothalamic germinoma and had a CR after two courses of carboplatin based regimen (the CEB regimen). He received 30 Gy of involved field radiotherapy and now at end of treatment after three months is well being without any sign of relapse. Neoadjuvant chemotherapy carboplatin based regimen was highly active in treating newly diagnosed CNS germinomas. Further chemotherapy studies eventually may permit additional dose reductions and/or elimination of radiotherapy for patients with CNS germinomas.

Full Text:



Journal of Solid Tumors

ISSN 1925-4067(Print)   ISSN 1925-4075(Online)

Copyright © Sciedu Press

To make sure that you can receive messages from us, please add the '' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.